The share price of Alpine Immune Sciences, Inc. (ALPN) now
Latest session on the 4th of December for
Alpine Immune Sciences, Inc. is positive
Trading Volume: 748005
Open: 15.25 /
High: 16.33 /
Low: 15.19
What analysts predict: $24
52-week High/Low: $16.26 / $5.81
50/200 Day Moving Average:
$11.79 / $10.46
This figure corresponds to the Average Price over the previous 50/200 days.
For Alpine Immune Sciences stocks, the 50-day moving average is the support level today.
For Alpine Immune Sciences stocks, the 200-day moving average is the support level today.
Are you interested in Alpine Immune Sciences, Inc. stocks and want to buy them, or are they already in your portfolio?
If yes, then on this page you will find useful information about the dynamics of the Alpine Immune Sciences
stock price in 2024, 2025, 2026, 2027, 2028.
How much will one Alpine Immune Sciences share be worth in
2024 - 2028?
When should I take profit in Alpine Immune Sciences stock?
When should I record a loss on Alpine Immune Sciences stock?
What are analysts' forecasts for Alpine Immune Sciences stock?
What is the future of Alpine Immune Sciences stock?
We forecast Alpine Immune Sciences stock performance using neural networks based on historical data on Alpine Immune Sciences stocks.
Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Alpine Immune Sciences stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals.
(Next month, 2024, 2025, 2026, 2027 and 2028)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Alpine Immune Sciences shares. This happens once a day.
Historical and forecast chart of Alpine Immune Sciences stock
The chart below shows the historical price of Alpine Immune Sciences stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Alpine Immune Sciences stock price can be found in the table below.
Long-term forecasts by years.
Alpine Immune Sciences, Inc. Is a biopharmaceutical company. The company is focused on the discovery and development of protein immunotherapy for the treatment of cancer, autoimmune and inflammatory diseases. The Company’s scientific platform uses a directed evolutionary process to convert native immune system proteins from the immunoglobulin superfamily (IgSF) into multipurpose therapeutic drugs capable of modulating the human immune system. Its candidate products include ALPN-101, ALPN-202 and ALPN-303. ALPN-101 is a dual inducible T cell costimulant (ICOS) and differentiation cluster 28 (CD28) antagonist for the treatment of autoimmune and inflammatory diseases. His cancer program is ALPN-202, a conditional CD28 co-stimulator and dual checkpoint inhibitor for cancer treatment. ALPN-303 is a dual antagonist of B-cell cytokines for the treatment of B-cell mediated diseases.
Trending Themes in the Healthcare Sector
Alpine Immune Sciences daily forecast for a month
Date
Target
Pes.
Opt.
Vol., %
Dec 07
15.64
15.17
15.85
4.51
Dec 08
15.81
15.57
16.18
3.90
Dec 09
15.40
15.03
15.81
5.18
Dec 10
15.41
15.26
15.54
1.84
Dec 11
15.53
15.24
15.87
4.10
Dec 12
15.97
15.76
16.44
4.31
Dec 13
15.69
15.45
15.90
2.89
Dec 14
15.89
15.61
16.36
4.80
Dec 15
15.31
14.85
15.67
5.48
Dec 16
15.15
14.75
15.35
4.10
Dec 17
14.99
14.75
15.40
4.40
Dec 18
14.72
14.59
14.92
2.26
Dec 19
15.07
14.75
15.51
5.17
Dec 20
14.82
14.57
15.17
4.10
Dec 21
15.11
14.75
15.51
5.18
Dec 22
15.66
15.33
16.02
4.51
Dec 23
15.72
15.59
15.87
1.84
Dec 24
15.44
15.23
15.64
2.70
Dec 25
15.28
14.90
15.60
4.68
Dec 26
14.94
14.69
15.29
4.10
Dec 27
14.94
14.54
15.09
3.79
Dec 28
15.02
14.84
15.29
3.00
Dec 29
15.32
14.96
15.77
5.37
Dec 30
15.61
15.37
15.87
3.24
Dec 31
15.87
15.54
16.09
3.57
Jan 01
16.09
15.65
16.22
3.67
Jan 02
15.93
15.64
16.14
3.17
Jan 03
15.63
15.38
15.93
3.63
Jan 04
15.30
15.05
15.42
2.47
Jan 05
15.45
15.16
15.70
3.60
Alpine Immune Sciences Daily Price Targets
Alpine Immune Sciences Stock Forecast 12-07-2023.
Forecast target price for 12-07-2023: $15.64. Negative dynamics for Alpine Immune Sciences shares will prevail with possible volatility of 4.313%. Pessimistic target level: 15.17 Optimistic target level: 15.85
Alpine Immune Sciences Stock Forecast 12-08-2023.
Forecast target price for 12-08-2023: $15.81. Positive dynamics for Alpine Immune Sciences shares will prevail with possible volatility of 3.751%. Pessimistic target level: 15.57 Optimistic target level: 16.18
Alpine Immune Sciences Stock Forecast 12-09-2023.
Forecast target price for 12-09-2023: $15.40. Negative dynamics for Alpine Immune Sciences shares will prevail with possible volatility of 4.921%. Pessimistic target level: 15.03 Optimistic target level: 15.81
Alpine Immune Sciences Stock Forecast 12-10-2023.
Forecast target price for 12-10-2023: $15.41. Positive dynamics for Alpine Immune Sciences shares will prevail with possible volatility of 1.808%. Pessimistic target level: 15.26 Optimistic target level: 15.54
Alpine Immune Sciences Stock Forecast 12-11-2023.
Forecast target price for 12-11-2023: $15.53. Positive dynamics for Alpine Immune Sciences shares will prevail with possible volatility of 3.943%. Pessimistic target level: 15.24 Optimistic target level: 15.87
Alpine Immune Sciences Stock Forecast 12-12-2023.
Forecast target price for 12-12-2023: $15.97. Positive dynamics for Alpine Immune Sciences shares will prevail with possible volatility of 4.134%. Pessimistic target level: 15.76 Optimistic target level: 16.44
Alpine Immune Sciences information and performance
Alpine Immune Sciences Address
201 ELLIOTT AVE. WEST, SUITE 230, SEATTLE, WA, US
Market Capitalization:
900 519 000 $
Market capitalization of the Alpine Immune Sciences, Inc. is the total market value of all issued shares of a company. It is calculated by the formula
multiplying the number of ALPN shares in the company outstanding by the market price of one share.
EBITDA:
-65 593 000 $
EBITDA of Alpine Immune Sciences is earnings before interest, income tax and depreciation of assets.
PE Ratio:
None
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio:
N/A
Price/earnings to growth
DPS:
N/A
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
DY:
N/A
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS:
-1.29
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY:
N/A
Quarterly Revenue Growth YOY:
0.2
Trailing PE:
-
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE:
-
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue:
22.48
Enterprise Value (EV) /Revenue
EV To EBITDA:
-12.43
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding:
58098000
Number of issued ordinary shares
Shares Float:
N/A
Number of freely tradable shares
Shares Short Prior Month:
N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio:
N/A
Percent Insiders:
N/A
Percent Institutions:
N/A
Alpine Immune Sciences (ALPN) stock dividend
Alpine Immune Sciences last paid dividends on 01/01/1970.
The next scheduled payment will be on 07/25/2017.
The amount of dividends is $0 per share.
If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment.
As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.
Last Split Factor:
Last Split Date:
01/01/1970
Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.
For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times.
It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and,
moreover, are not trading signals.
When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market
as a result of using the information contained on the site.
This website uses cookies to ensure you get the best experience on our website